AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012
Nov 20, 2012
29977_dirs_2012-11-20_15748fcb-7ab5-4b4c-94c5-f0c752dd1661.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-11-19
Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-12 | Common Stock | G | 3786.0 | $0.0 | Disposed | 167761.0 | Indirect |
| 2012-03-30 | Common Stock | G | 1852.0 | $0.0 | Disposed | 165909.0 | Indirect |
| 2012-07-12 | Common Stock | G | 1860.0 | $0.0 | Disposed | 164049.0 | Indirect |
| 2012-10-09 | Common Stock | G | 1392.0 | $0.0 | Disposed | 162657.0 | Indirect |
| 2012-07-24 | Common Stock | G | 19947.0 | $0.0 | Disposed | 59844.0 | Indirect |
| 2012-07-24 | Common Stock | G | 19947.0 | $0.0 | Disposed | 39897.0 | Indirect |
| 2012-07-24 | Common Stock | G | 19947.0 | $0.0 | Disposed | 19950.0 | Indirect |
| 2012-09-04 | Common Stock | G | 19947.0 | $0.0 | Disposed | 3.0 | Indirect |
| 2012-11-19 | Common Stock | S | 30800.0 | $160.59 | Disposed | 129200.0 | Indirect |
| 2012-11-19 | Common Stock | S | 1700.0 | $161.06 | Disposed | 127500.0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 56946.0 | Direct |
| Common Stock | 82410.0 | Indirect |
| Common Stock | 2329.0 | Indirect |
| Common Stock | 15162.0 | Indirect |
| Common Stock | 1203.0 | Indirect |
Footnotes
F1: A GRAT of which the reporting person is a donor and trustee distributed to the adult children of the reporting person shares of Regeneron common stock in accordance with the terms of the GRAT.
F2: Represents volume-weighted average price of sales of 30,800 shares of Company stock on November 19, 2012 at prices ranging from $160.63 to $160.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 19, 2012 at each separate price.
F3: By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
F4: Represents volume-weighted average price of sales of 1,700 shares of Company stock on November 19, 2012 at prices ranging from $161.00 to $161.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 19, 2012 at each separate price.
F5: By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.